CytomX Therapeutics, Inc. insider trading activity
Understanding Insider Activity at CytomX Therapeutics, Inc.
Welcome to our dedicated page for CytomX Therapeutics, Inc. (Nasdaq: CTMX) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by CytomX Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for CytomX Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for CTMX| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| CTMX | 10:01:51 PM 8/22/2024 | Landau Jeffrey B(Chief Business Officer) sold 4181 shares of CytomX Therapeutics, Inc. (CTMX) for ~$5142 | Filing |
| CTMX | 10:01:09 PM 8/22/2024 | BELVIN MARCIA(SVP, Chief Scientific Officer) sold 4181 shares of CytomX Therapeutics, Inc. (CTMX) for ~$5142 | Filing |
| CTMX | 10:00:30 PM 8/22/2024 | ROWLAND LLOYD A(General Counsel) sold 4181 shares of CytomX Therapeutics, Inc. (CTMX) for ~$5142 | Filing |
| CTMX | 9:59:48 PM 8/22/2024 | Ogden Christopher(Chief Financial Officer) sold 1984 shares of CytomX Therapeutics, Inc. (CTMX) for ~$2440 | Filing |
| CTMX | 9:58:38 PM 8/22/2024 | McCarthy Sean A.(CEO) sold 13898 shares of CytomX Therapeutics, Inc. (CTMX) for ~$17094 | Filing |
| CTMX | 8:41:27 PM 3/21/2024 | ROWLAND LLOYD A(General Counsel) sold 5268 shares of CytomX Therapeutics, Inc. (CTMX) for ~$11010 | Filing |
| CTMX | 8:40:09 PM 3/21/2024 | McCarthy Sean A.(CEO) sold 20223 shares of CytomX Therapeutics, Inc. (CTMX) for ~$42266 | Filing |
| CTMX | 8:38:57 PM 3/21/2024 | Ogden Christopher(SVP, Finance and Accounting) sold 2971 shares of CytomX Therapeutics, Inc. (CTMX) for ~$6209 | Filing |
| CTMX | 8:37:36 PM 3/21/2024 | BELVIN MARCIA(SVP, Chief Scientific Officer) sold 12795 shares of CytomX Therapeutics, Inc. (CTMX) for ~$26741 | Filing |
| CTMX | 8:36:46 PM 3/21/2024 | Landau Jeffrey B(Chief Business Officer) sold 6562 shares of CytomX Therapeutics, Inc. (CTMX) for ~$13714 | Filing |
| CTMX | 9:16:04 PM 12/22/2023 | McCarthy Sean A.(CEO) sold 13551 shares of CytomX Therapeutics, Inc. (CTMX) for ~$18700 | Filing |
| CTMX | 9:14:32 PM 12/22/2023 | BELVIN MARCIA(SVP, Chief Scientific Officer) sold 4077 shares of CytomX Therapeutics, Inc. (CTMX) for ~$5626 | Filing |
| CTMX | 9:12:57 PM 12/22/2023 | Landau Jeffrey B(Chief Business Officer) sold 4077 shares of CytomX Therapeutics, Inc. (CTMX) for ~$5626 | Filing |
| CTMX | 9:11:46 PM 12/22/2023 | ROWLAND LLOYD A(General Counsel) sold 4077 shares of CytomX Therapeutics, Inc. (CTMX) for ~$5626 | Filing |
| CTMX | 9:10:48 PM 12/22/2023 | Ogden Christopher(SVP, Finance and Accounting) sold 1990 shares of CytomX Therapeutics, Inc. (CTMX) for ~$2746 | Filing |
| CTMX | 11:16:52 PM 9/22/2023 | BELVIN MARCIA(SVP, Chief Scientific Officer) sold 4119 shares of CytomX Therapeutics, Inc. (CTMX) for ~$5354 | Filing |
| CTMX | 11:15:12 PM 9/22/2023 | Landau Jeffrey B(Chief Business Officer) sold 4119 shares of CytomX Therapeutics, Inc. (CTMX) for ~$5354 | Filing |
| CTMX | 11:13:47 PM 9/22/2023 | McCarthy Sean A.(CEO) sold 14601 shares of CytomX Therapeutics, Inc. (CTMX) for ~$18981 | Filing |
| CTMX | 11:12:50 PM 9/22/2023 | ROWLAND LLOYD A(General Counsel) sold 5486 shares of CytomX Therapeutics, Inc. (CTMX) for ~$7131 | Filing |
| CTMX | 11:56:04 PM, 3/31/2023 | Jones Elaine V purchased 5000 shares of CytomX Therapeutics, Inc. (CTMX) for ~$7750 | Filing |
Discover the Complete Picture 🔒
Currently viewing just 6 of 20 insider filings.
Register now to dive deeper and explore the full dataset.